Press Release Cortexyme Announces Third Quarter 2019 Financial Results and Provides Business Update By admin | Press Release
EventsPress Release Cortexyme Announces Oral Presentation on COR388 at Clinical Trials on Alzheimer’s Disease 2019 By admin | Events, Press Release
EventsPress Release Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019 By admin | Events, Press Release
News Investor Business Daily – Why Alzheimer’s Treatment Hopes Endure Despite High-Profile Drug Failures By admin | News
